Albert S Baldwin Selected Research

Brain Neoplasms (Brain Tumor)

2/2016	Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.
11/2011	Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert S Baldwin Research Topics

Disease

41	Neoplasms (Cancer) 01/2024 - 08/2002
9	Carcinogenesis 01/2024 - 08/2002
6	Inflammation (Inflammations) 01/2021 - 10/2004
6	Infections 01/2017 - 02/2003
4	Triple Negative Breast Neoplasms 07/2023 - 01/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 10/2008
4	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2002
3	Squamous Cell Carcinoma of Head and Neck 01/2023 - 09/2007
3	Breast Neoplasms (Breast Cancer) 12/2019 - 07/2012
3	Lung Neoplasms (Lung Cancer) 01/2019 - 05/2010
3	Hepatocellular Carcinoma (Hepatoma) 04/2012 - 01/2007
3	Necrosis 04/2007 - 06/2003
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2018
2	Bites and Stings (Sting) 11/2023 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 10/2016 - 11/2011
2	Brain Neoplasms (Brain Tumor) 02/2016 - 11/2011
2	Glioma (Gliomas) 01/2014 - 02/2003
2	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 01/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013 - 02/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2011 - 01/2006
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2011 - 04/2007
2	Prostatic Neoplasms (Prostate Cancer) 06/2008 - 07/2007
2	Colitis 02/2008 - 12/2007
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2003 - 01/2002
2	Hematologic Neoplasms (Hematological Malignancy) 11/2002 - 08/2002
1	Cholangiocarcinoma 05/2024
1	Hypoxia (Hypoxemia) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Muscular Atrophy (Muscle Atrophy) 04/2018
1	Adenocarcinoma 04/2018
1	Anorexia 04/2018
1	Cachexia 04/2018
1	Nausea 04/2018
1	Acute Lung Injury 04/2017
1	Pneumonia (Pneumonitis) 04/2017
1	Herpes Simplex 01/2017
1	Tics (Tic) 01/2016

Drug/Important Bio-Agent (IBA)

28	NF-kappa B (NF-kB)IBA 01/2022 - 01/2002
18	Transcription Factors (Transcription Factor)IBA 07/2023 - 08/2002
11	Phosphotransferases (Kinase)IBA 01/2024 - 07/2007
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2007
7	I-kappa B KinaseIBA 10/2008 - 06/2003
5	CytokinesIBA 10/2018 - 02/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 02/2003
5	NF-KappaB Inhibitor alphaIBA 02/2008 - 02/2003
4	Small Interfering RNA (siRNA)IBA 01/2024 - 01/2014
4	Interleukin-8 (Interleukin 8)IBA 01/2019 - 10/2004
4	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2018 - 03/2003
3	Peptides (Polypeptides)IBA 07/2011 - 12/2007
3	Insulin (Novolin)FDA Link 08/2009 - 02/2003
3	PS519IBA 11/2008 - 03/2003
3	Oncogene Proteins (Oncogene Protein)IBA 06/2008 - 01/2006
2	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 08/2009
2	Protein Isoforms (Isoforms)IBA 01/2024 - 10/2008
2	TNF Receptor-Associated Factor 3IBA 01/2023 - 01/2022
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2018
2	Antipsychotic Agents (Antipsychotics)IBA 12/2019 - 10/2018
2	Thioridazine (Mellaril)FDA LinkGeneric 12/2019 - 10/2018
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017 - 07/2012
2	InterferonsIBA 01/2017 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2009
2	Mechanistic Target of Rapamycin Complex 2IBA 04/2016 - 11/2011
2	MethyltransferasesIBA 01/2016 - 01/2009
2	Glycogen Synthase Kinase 3IBA 06/2013 - 10/2008
2	bcr-abl Fusion ProteinsIBA 01/2013 - 02/2008
2	Protein Kinases (Protein Kinase)IBA 01/2013 - 11/2011
2	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 02/2008
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2011 - 08/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009 - 07/2008
2	ChromatinIBA 01/2009 - 06/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2008 - 07/2007
2	Proteasome InhibitorsIBA 03/2003 - 11/2002
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 05/2024
1	SulfonamidesIBA 11/2023
1	Estrogen Receptor alphaIBA 01/2023
1	CateninsIBA 11/2022
1	SCH772984IBA 01/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 12/2019
1	Dopamine (Intropin)FDA LinkGeneric 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2019
1	Phenformin (Fenformin)IBA 10/2018
1	UbiquitinIBA 04/2018
1	Cisplatin (Platino)FDA LinkGeneric 04/2018
1	FibrinIBA 01/2018
1	Factor XIIIaIBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2017
1	Inositol (Myoinositol)IBA 01/2017
1	PolyphosphatesIBA 01/2017
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	TensinsIBA 01/2017

Therapy/Procedure

12	Therapeutics 01/2023 - 08/2002
8	Drug Therapy (Chemotherapy) 04/2018 - 08/2002
1	Immunotherapy 09/2018
1	Hematopoietic Stem Cell Transplantation 04/2017